Editor’s Note October 17, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
Articles by Herina Ayot
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Promising Medical Technologies from Leading Universities to Showcase at 5th Annual OneMedForum
Significant Advances in Translational Medicine Result from “Coulter Process”.
Editor’s Note October 3, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
Sector Reports on Investment Opportunities in Health and Medicine Featured at 5th Annual OneMedForum
OneMedPlace announced today that OneMedForum San Francisco 2012 will feature special reports in 8 healthcare sectors.
The Wallace H. Coulter Foundation Optimizes Academia Process
“We have very clear timelines, milestones, and we define the critical experiment that, if it’s successful will bring value to the technology and make it ready for follow-up funding.”
Vasomedical Proves Itself A Company To Watch On The Fast Track to Growth
With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.
NeoStem Expected To Have Short and Long Term Value Drivers
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
Editor’s Note September 19, 2011
OneMedSentinel is pleased to bring you another round of stories and interviews with some of the most promising companies and technologies, as well as innovative […]
ImmunoGenetix Discovers a Safer Approach To HIV Treatment
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed a therapeutic DNA based composition to treat HIV, GenePro.